Antithrombotic therapies: anticoagulation and thrombolysis.
Explore this paper's citation graph
Summary
Optimal dosing, intensity and duration strategies for anticoagulation as well as thrombolytic regimens that maximize efficacy and safety need to be determined through well-designed clinical trials using use of a risk-stratified approach.
- Type
- review
- Published
- 2013-12-01
- Cited by
- 12
- References
- 58
- OpenAlex
- https://openalex.org/W2053426
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:37177307
Keywords
Medicine, Antithrombotic, Intensive care medicine, Dosing, Thrombosis
References
- Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial.
- Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children
- Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial.
- Streptokinase of heparin in the treatment of deep vein thrombosis. Follow-up results of a prospective study.
- Pediatric Venous Thromboembolism in the United States: A Tertiary Care Complication of Chronic Diseases
- Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy.
- Venous interventions in children.
- Intracerebral Hemorrhage During Fibrinolytic Therapy in Children: A Review of the Literature of the Last Thirty Years
- Thrombolytic therapy in children.
- Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years
- Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.
- Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
- Deep Vein Thrombosis: Thrombolysis in the Pediatric Population
- An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.
- Catheter-directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis.
- Novel paediatric anticoagulants: a review of the current literature
- Low-Dose Tissue Plasminogen Activator Thrombolysis in Children
- A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial
- Catheter‐directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short‐term patency
- Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Cited by
- New developments in pediatric venous thromboembolism and anticoagulation, including the target-specific oral anticoagulants
- Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.
- Management and Outcomes of Patients with Occlusive Thrombosis after Pediatric Cardiac Surgery.
- Venous Thromboembolic Disease in Children and Adolescents.
- Physiological, Pharmacological and Clinical Factors Associated with Thrombosis in Pediatric Patients Undergoing Cardiac Surgery with Cardiopulmonary Bypass
- Thrombosis of the Abdominal Veins in Childhood
- Venous thromboembolism in childhood: where is Brazil after 20 years?
- The Role of Interventional Radiology in the Treatment of Acute Thrombosis and Chronic Veno-Occlusive Disease in Children and Adolescents.
- Is This Working “Well” for Pediatrics? The Diagnosis and Treatment of Thromboembolic Disease in a Patient With Protein C Deficiency
- Tissue Plasminogen Activator Use in Pediatric Patients: A Single Center Experience
- 38 – Bleeding and Thrombosis
- Diagnosis, Prevention, and Management of Venous Thromboembolism in the Adolescent Female
Related papers
- Seasonal variations of deep vein thrombosis and its influence on the location of the thrombus.
- Late results of treatment of deep vein thrombosis
- OC 34.3 Walking Capacity in Patients with Acute Deep Vein Thrombosis is Associated with the Location of Thrombosis and is Reduced in Patients with a History of Previous Deep Vein Thrombosis
- A Histo-Pathological Study of Fatal Pulmonary Thromboembolism and Deep Vein Thrombosis: In the Study of Deep Vein Thrombosis among Forty Patients with Pulmonary Thromboembolism
- Prediction Tool for Thrombi Associated With Peripherally Inserted Central Catheters
- Impact of venography on the diagnosis and management of deep vein thrombosis.
- Compression sonography in patients with indeterminate or low-probability lung scans: lack of usefulness in the absence of both symptoms of deep-vein thrombosis and thromboembolic risk factors.
- Deep vein thrombosis in hospitalized patients: a review of evidence-based guidelines for prevention.
- Prevention of deep vein thrombosis after total knee replacement